Answers are grounded in this paper and cite their sources.
The clinical management of leprosy type 1 and type 2 reactions poseschallenges mainly because they can cause severe nerve injury and disability. No laboratory test or marker is available for the diagnosis or prognosis of leprosy. This study screened IL-18 level in plasma in samples to identify circulating biomarker associated with type 1 and type 2 lepra reactions. In this study IL-18 level was compared in T1R ( IL-18 level was measured using commercial kit. IL-18 level was significantly higher in the T1R and T2R groups when compared to the NRL and NHC groups (p=0.0001). The level was significantly different in T1R group and T2R group (p=0.0343). The BTR group showed the highest IL-18 plasma levels among the other groups in the disease spectrum in reactional leprosy patients (meansD) (3483.381035.63). Bacteriological index (BI), was showed negative correlation with IL-18 plasma levels. The results specify that IL-18 plasma levels are elevated during T1R and T2R leprosy reactions and thus may play a role in the regulation of inflammatory responses associated with reactions in leprosy.
No takes yet. Share an insight, caveat, or question.
Yadav et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: